06/11/2024: Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment

05/29/2024: Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the treatment of atrial fibrillation

05/09/2024: Kardium announces enhanced clinical capabilities of the Globe® System with Right Atrial ablation and Hybrid Energy ablation

08/05/2021: Kardium selected as Medical/Digital Technology Company of the Year

Life Sciences BC has selected Kardium Inc. as the Medical/Digital Technology Company of the Year.

07/20/2021: More precise and effective: Innovative catheter technology in the cardiac catheterization laboratory

Cardiologists at the RHÖN-KLINIKUM Campus Bad Neustadt apply state-of-the-art single catheter complete solution for the treatment of atrial fibrillation for the first time.

01/25/2021: B.C. heart device firm Kardium founded by Creo executives raises $115-million from Fidelity, T. Rowe Price ahead of going public

Kardium's Globe Mapping and Ablation System is intended to disrupt a roughly $6-billion market for treating atrial fibrillation, which is expected to grow by 15 per cent a year as Baby Boomers age.